BG103852A - Cog-2 selective carprophene for the treatment of pains and inflammations in dogs - Google Patents
Cog-2 selective carprophene for the treatment of pains and inflammations in dogsInfo
- Publication number
- BG103852A BG103852A BG103852A BG10385299A BG103852A BG 103852 A BG103852 A BG 103852A BG 103852 A BG103852 A BG 103852A BG 10385299 A BG10385299 A BG 10385299A BG 103852 A BG103852 A BG 103852A
- Authority
- BG
- Bulgaria
- Prior art keywords
- cog
- activity
- acids
- inhibition
- dogs
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pain & Pain Management (AREA)
- Rheumatology (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Indole Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US4563597P | 1997-05-05 | 1997-05-05 | |
| PCT/IB1998/000662 WO1998050033A1 (fr) | 1997-05-05 | 1998-05-01 | Carprofene inhibant selectivement cox-2 et utilise dans le traitement de la douleur et des inflammations chez les chiens |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| BG103852A true BG103852A (en) | 2000-06-30 |
Family
ID=21939053
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| BG103852A BG103852A (en) | 1997-05-05 | 1999-11-03 | Cog-2 selective carprophene for the treatment of pains and inflammations in dogs |
Country Status (32)
| Country | Link |
|---|---|
| EP (1) | EP0988034A1 (fr) |
| JP (1) | JP2000513020A (fr) |
| KR (2) | KR20040004406A (fr) |
| CN (1) | CN1255059A (fr) |
| AP (1) | AP9801234A0 (fr) |
| AR (2) | AR011726A1 (fr) |
| AU (1) | AU6932198A (fr) |
| BG (1) | BG103852A (fr) |
| BR (1) | BR9808720A (fr) |
| CA (1) | CA2288759A1 (fr) |
| DZ (1) | DZ2479A1 (fr) |
| EA (1) | EA003696B1 (fr) |
| GT (1) | GT199800063A (fr) |
| HR (1) | HRP980244A2 (fr) |
| HU (1) | HUP0001286A3 (fr) |
| ID (1) | ID21311A (fr) |
| IL (1) | IL132570A0 (fr) |
| IS (1) | IS5220A (fr) |
| MA (1) | MA26491A1 (fr) |
| NO (1) | NO995389L (fr) |
| NZ (1) | NZ500183A (fr) |
| OA (1) | OA11213A (fr) |
| PA (1) | PA8450601A1 (fr) |
| PE (1) | PE72599A1 (fr) |
| PL (1) | PL337003A1 (fr) |
| SK (1) | SK148199A3 (fr) |
| TN (1) | TNSN98059A1 (fr) |
| TW (1) | TW590773B (fr) |
| UY (1) | UY24989A1 (fr) |
| WO (1) | WO1998050033A1 (fr) |
| YU (1) | YU55899A (fr) |
| ZA (1) | ZA983722B (fr) |
Families Citing this family (28)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6245797B1 (en) | 1997-10-22 | 2001-06-12 | Merck & Co., Inc. | Combination therapy for reducing the risks associated with cardio-and-cerebrovascular disease |
| AU2003204888B2 (en) * | 1998-05-22 | 2005-07-28 | Pfizer Products Inc. | Treating or Preventing the Early Stages of Degeneration of Articular Cartilage or Subchondral Bone in Mammals Using Carprofen and Derivatives |
| US6506785B2 (en) | 1998-05-22 | 2003-01-14 | Pfizer, Inc. | Treating or preventing the early stages of degeneration of articular cartilage or subchondral bone in mammals using carprofen and derivatives |
| AU764872B2 (en) * | 1998-10-23 | 2003-09-04 | Merck Frosst Canada & Co. | Combination product comprising an E-type prostaglandin ligand and a cox-2 selective inhibitor and methods of use |
| WO2000053149A2 (fr) * | 1999-03-10 | 2000-09-14 | G.D. Searle & Co. | Procede et composition se rapportant a l'administration d'un inhibiteur de la cyclo-oxygenase-2 |
| WO2001034204A1 (fr) * | 1999-11-11 | 2001-05-17 | Eli Lilly And Company | Produits composes oncolytiques destines au traitement du cancer |
| JP2004521856A (ja) * | 2000-05-15 | 2004-07-22 | メルク フロスト カナダ アンド カンパニー | Ｃｏｘ−２選択的阻害剤およびトロンボキサン阻害剤を用いる併用療法ならびにそのための組成物 |
| RU2003100874A (ru) | 2000-06-13 | 2004-06-27 | Вайс (Us) | Болеутоляющие и противовоспалительные составы, содержащие ингибиторы циклооксигеназы-2 |
| DE10032132A1 (de) * | 2000-07-01 | 2002-01-17 | Lohmann Therapie Syst Lts | Dermales Therapeutisches System enthaltend nichtsteroidale Antiphlogistika mit selektiver COX-2-Hemmung |
| US7189504B2 (en) | 2000-08-07 | 2007-03-13 | Vanderbilt University | Compositions and methods for detecting and quantifying COX-2 activity and 2-arachidonylglycerol metabolites |
| US20040209959A1 (en) * | 2001-07-16 | 2004-10-21 | Edward Hogestatt | Congeners of acetaminophen and related compounds as substrates for fatty acid conjugation and their use in treatment of pain, fever and inflammation |
| CA2519189C (fr) | 2003-05-07 | 2012-07-17 | Osteologix A/S | Sels de strontium solubles dans l'eau pour le traitement de maladies des cartilages et/ou des os |
| KR100780983B1 (ko) * | 2003-07-31 | 2007-11-30 | 파마시아 앤드 업존 캄파니 엘엘씨 | 소염제의 분산성 제제 |
| WO2006123247A2 (fr) * | 2005-05-20 | 2006-11-23 | Pfizer Limited | Combinaisons synergiques |
| WO2008122967A2 (fr) | 2007-04-04 | 2008-10-16 | Sigmoid Pharma Limited | Composition pharmaceutique orale |
| WO2008132707A1 (fr) | 2007-04-26 | 2008-11-06 | Sigmoid Pharma Limited | Fabrication de minicapsules multiples |
| US9278070B2 (en) | 2009-05-18 | 2016-03-08 | Sigmoid Pharma Limited | Composition comprising oil drops |
| EP2464341B1 (fr) | 2009-08-12 | 2022-07-06 | Sublimity Therapeutics Limited | Compositions immunomodulatrices comprenant une matrice polymère et une phase huileuse |
| GB201020032D0 (en) | 2010-11-25 | 2011-01-12 | Sigmoid Pharma Ltd | Composition |
| GB201212010D0 (en) | 2012-07-05 | 2012-08-22 | Sigmoid Pharma Ltd | Formulations |
| GB201319791D0 (en) | 2013-11-08 | 2013-12-25 | Sigmoid Pharma Ltd | Formulations |
| DK3113774T3 (da) | 2014-03-06 | 2022-03-07 | Elanco Animal Health Incorporated | Sammensætninger af grapiprant og fremgangsmåder til anvendelse deraf |
| EA036036B1 (ru) | 2014-11-07 | 2020-09-16 | Сигмойд Фарма Лимитед | Композиции, содержащие циклоспорин |
| US12109218B2 (en) | 2014-12-09 | 2024-10-08 | Aratana Therapeutics, Inc. | Compositions of grapiprant and methods for using the same |
| MX2017009011A (es) * | 2015-01-09 | 2017-10-02 | Jaguar Animal Health | Metodos para tratar la diarrea en animales de compañia. |
| JP2023520367A (ja) * | 2020-03-25 | 2023-05-17 | エスアールアイ インターナショナル | リポキシゲナーゼ阻害剤 |
| US11116737B1 (en) | 2020-04-10 | 2021-09-14 | University Of Georgia Research Foundation, Inc. | Methods of using probenecid for treatment of coronavirus infections |
| KR102404883B1 (ko) | 2020-11-30 | 2022-06-07 | (주)이노보테라퓨틱스 | 벤즈브로마론을 포함하는 켈로이드 또는 비대흉터 예방 또는 치료용 약학 조성물 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3896145A (en) * | 1972-07-24 | 1975-07-22 | Hoffmann La Roche | Carbazoles |
| CA1319886C (fr) * | 1987-02-03 | 1993-07-06 | Alberto Ferro | Solutions de micelles mixtes |
-
1998
- 1998-03-02 DZ DZ980089A patent/DZ2479A1/fr active
- 1998-04-30 TW TW087106689A patent/TW590773B/zh not_active IP Right Cessation
- 1998-05-01 AU AU69321/98A patent/AU6932198A/en not_active Abandoned
- 1998-05-01 EA EA199900895A patent/EA003696B1/ru not_active IP Right Cessation
- 1998-05-01 YU YU55899A patent/YU55899A/sh unknown
- 1998-05-01 ID IDP980651A patent/ID21311A/id unknown
- 1998-05-01 SK SK1481-99A patent/SK148199A3/sk unknown
- 1998-05-01 HU HU0001286A patent/HUP0001286A3/hu unknown
- 1998-05-01 JP JP10547869A patent/JP2000513020A/ja active Pending
- 1998-05-01 CN CN98804845A patent/CN1255059A/zh active Pending
- 1998-05-01 NZ NZ500183A patent/NZ500183A/en unknown
- 1998-05-01 EP EP98915041A patent/EP0988034A1/fr not_active Withdrawn
- 1998-05-01 IL IL13257098A patent/IL132570A0/xx unknown
- 1998-05-01 BR BR9808720-7A patent/BR9808720A/pt not_active IP Right Cessation
- 1998-05-01 CA CA002288759A patent/CA2288759A1/fr not_active Abandoned
- 1998-05-01 WO PCT/IB1998/000662 patent/WO1998050033A1/fr not_active Application Discontinuation
- 1998-05-01 KR KR10-2003-7005258A patent/KR20040004406A/ko not_active Application Discontinuation
- 1998-05-01 KR KR1019997010252A patent/KR20010012300A/ko not_active Application Discontinuation
- 1998-05-01 PL PL98337003A patent/PL337003A1/xx unknown
- 1998-05-04 MA MA25059A patent/MA26491A1/fr unknown
- 1998-05-04 PE PE1998000335A patent/PE72599A1/es not_active Application Discontinuation
- 1998-05-04 TN TNTNSN98059A patent/TNSN98059A1/fr unknown
- 1998-05-04 UY UY24989A patent/UY24989A1/es not_active Application Discontinuation
- 1998-05-04 ZA ZA9803722A patent/ZA983722B/xx unknown
- 1998-05-04 GT GT199800063A patent/GT199800063A/es unknown
- 1998-05-04 AP APAP/P/1998/001234A patent/AP9801234A0/en unknown
- 1998-05-05 AR ARP980102089A patent/AR011726A1/es unknown
- 1998-05-05 HR HR60/045,635A patent/HRP980244A2/hr not_active Application Discontinuation
- 1998-05-05 PA PA19988450601A patent/PA8450601A1/es unknown
-
1999
- 1999-10-19 IS IS5220A patent/IS5220A/is unknown
- 1999-11-02 OA OA9900242A patent/OA11213A/en unknown
- 1999-11-03 BG BG103852A patent/BG103852A/xx unknown
- 1999-11-04 NO NO995389A patent/NO995389L/no not_active Application Discontinuation
-
2003
- 2003-04-09 AR ARP030101251A patent/AR039628A2/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| BG103852A (en) | Cog-2 selective carprophene for the treatment of pains and inflammations in dogs | |
| DE69805846D1 (de) | Verwendung von 3-benzoylphenylessigsäuren, deren estern oder amiden zur behandlung von glc1a glaukom | |
| DE59711321D1 (de) | Neue substituierte pyrazolderivate zur behandlung von herzkreislauferkrankungen | |
| ATE407573T1 (de) | Verwendung von lokal verabreichten lysine zur verbesserung der vaskularen funktion | |
| DE69626539D1 (de) | topische Verwendung von Vitamin D zur Behandlung von Augenerkrankungen | |
| NO983019L (no) | Fremgangsmåte for inhibering av fotoaldring av hud | |
| WO1999046279A3 (fr) | INHIBITEURS DE LA 17β-HYDROXYSTEROIDE DESHYDROGENASE DU TYPE 5 ET DU TYPE 3 ET METHODES D'UTILISATION ASSOCIEES | |
| CA2168963A1 (fr) | Agent preventif et curatif contre les maladies provoquees par la formation de fibrinoides ou de thrombus dans les poumons et modele animal pour ces maladies | |
| DE69526183D1 (de) | 3-benzoylphenylessigsäure-derivate enthaltende topische zusammensetzungen zur behandlung der ophthalmischen entzündungserkrankungen | |
| WO1994020062A3 (fr) | Balanoides utilisables comme inhibiteurs de la proteine kinase c | |
| ATE321548T1 (de) | Verwendung von statin zur behandlung von hauterkrankungen | |
| DE69613693D1 (de) | 2-heteroarylalkenylderivate der cyclopentano-heptan(heptaen)säure als therapeutisches mittel zur behandlung des erhöhten augeninnendruckes | |
| ES2162051T3 (es) | Preparacion dermatologica para tratar queratosis actinicas. | |
| DE69611452D1 (de) | Benzothiophenderivate | |
| GR3034575T3 (en) | Steroid nitrite ester derivatives useful as anti-inflammatory drugs | |
| ATE198751T1 (de) | Azoderivate von 5-aminosalicylsäure zur behandlung von enzündlichen darmerkrankungen | |
| NO20006506D0 (no) | Anvendelse av valproinsyreanalog for behandlingen og forebyggelsen av migrene og affektive sykdommer | |
| ZA978400B (en) | Use of inhibitors of the activity of retinoic acid to promote healing. | |
| CA2362888A1 (fr) | Utilisation d'acides r-aryl-propioniques pour la production de medicaments, pour le traitement de maladies touchant l'homme et l'animal et sur lesquelles l'inhibition de l'activation du facteur de transcription nf-kb peut exercer une influence d'un point de vue therapeutique | |
| IT1254521B (it) | Derivati della 2-ammino-tetralina attivi sul sistema cardiovascolare | |
| DE69735417D1 (de) | 2,5-dihydroxybenzylsulfonderivate zur behandlung von sexuellen störungen | |
| DE59900286D1 (de) | Verwendung von sphingosin-1-phosphat, sphingosin-1-phosphat-derivaten und/oder deren gemische zur behandlung von entzündlichen hautkrankheiten | |
| MX26142A (es) | Derivados de acido benzoico para tratar enfermedades relacionadas con leucotrieno. | |
| ATE238796T1 (de) | Nukleosidderivative in kombinationspräparaten zur behandlung von hsv krankheiten | |
| DE69739190D1 (de) | Arzneimittel zur behandlung von oculären kreislauferkrankungen |